German Oncological Data Standard (GOLD) - Local Development build (v0.1.0) built by the FHIR (HL7® FHIR® Standard) Build Tools. See the Directory of published versions
{
"resourceType" : "Observation",
"id" : "example-tnm-rpT3mpN0icM0R1is",
"meta" : {
"profile" : [
🔗 "https://www.vision-zero-oncology.de/fhir/StructureDefinition/uicc-tnm"
]
},
"text" : {
"status" : "extensions",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative: Observation</b><a name=\"example-tnm-rpT3mpN0icM0R1is\"> </a></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource Observation "example-tnm-rpT3mpN0icM0R1is" </p><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-uicc-tnm.html\">Profile UICC TNM</a></p></div><p><b>status</b>: final</p><p><b>code</b>: International Union Against Cancer (tumor staging) <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"https://browser.ihtsdotools.org/\">SNOMED CT</a>#258235000; <a href=\"https://loinc.org/\">LOINC</a>#21902-2 "Stage group.pathology Cancer")</span></p><p><b>subject</b>: <a href=\"Patient-ExamplePatient.html\">Patient/ExamplePatient</a> " BACH"</p><p><b>effective</b>: 2022-03-07</p><p><b>value</b>: Stage IIB <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (unknown#IIB)</span></p><p><b>hasMember</b>: <a href=\"Observation-example-tnm-R1.html\">Observation/example-tnm-R1</a></p><blockquote><p><b>component</b></p><p><b>code</b>: r - Tumor recurrence (tumor staging) <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"https://browser.ihtsdotools.org/\">SNOMED CT</a>#277647002)</span></p><p><b>value</b>: r <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (unknown#r)</span></p></blockquote><blockquote><p><b>component</b></p><p><b>Extension UICC TNM Prefix CPU</b>: p <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (unknown#p)</span></p><p><b>code</b>: Primary tumor.pathology Cancer <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"https://loinc.org/\">LOINC</a>#21899-0)</span></p><p><b>value</b>: T3 <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (unknown#T3)</span></p></blockquote><blockquote><p><b>component</b></p><p><b>code</b>: m - Multiple tumors (tumor staging) <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"https://browser.ihtsdotools.org/\">SNOMED CT</a>#277650004)</span></p><p><b>value</b>: (m) <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (unknown#m)</span></p></blockquote><blockquote><p><b>component</b></p><p><b>Extension UICC TNM Prefix CPU</b>: p <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (unknown#p)</span></p><p><b>Extension UICC TNM Suffix ITC</b>: (i+) <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (unknown#i+)</span></p><p><b>code</b>: Regional lymph nodes.pathology [Class] Cancer <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"https://loinc.org/\">LOINC</a>#21900-6)</span></p><p><b>value</b>: N0 <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (unknown#N0)</span></p></blockquote><blockquote><p><b>component</b></p><p><b>Extension UICC TNM Prefix CPU</b>: c <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (unknown#c)</span></p><p><b>code</b>: Distant metastases.clinical [Class] Cancer <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"https://loinc.org/\">LOINC</a>#21907-1)</span></p><p><b>value</b>: M0 <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (unknown#M0)</span></p></blockquote></div>"
},
"status" : "final",
"code" : {
"coding" : [
{
"system" : "http://snomed.info/sct",
"code" : "258235000",
"display" : "International Union Against Cancer (tumor staging)"
},
{
"system" : "http://loinc.org",
"code" : "21902-2",
"display" : "Stage group.pathology Cancer"
}
]
},
"subject" : {
🔗 "reference" : "Patient/ExamplePatient"
},
"effectiveDateTime" : "2022-03-07",
"valueCodeableConcept" : {
"coding" : [
{
"system" : "urn:oid:2.16.840.1.113883.15.16",
"code" : "IIB",
"display" : "Stage IIB"
}
]
},
"hasMember" : [
{
🔗 "reference" : "Observation/example-tnm-R1"
}
],
"component" : [
{
"code" : {
"coding" : [
{
"system" : "http://snomed.info/sct",
"code" : "277647002",
"display" : "r - Tumor recurrence (tumor staging)"
}
]
},
"valueCodeableConcept" : {
"coding" : [
{
"system" : "urn:oid:2.16.840.1.113883.15.16",
"code" : "r",
"display" : "r"
}
]
}
},
{
"extension" : [
{
"url" : "https://www.vision-zero-oncology.de/fhir/StructureDefinition/uicc-tnm-prefix-cpu",
"valueCodeableConcept" : {
"coding" : [
{
"system" : "urn:oid:2.16.840.1.113883.15.16",
"code" : "p",
"display" : "p"
}
]
}
}
],
"code" : {
"coding" : [
{
"system" : "http://loinc.org",
"code" : "21899-0",
"display" : "Primary tumor.pathology Cancer"
}
]
},
"valueCodeableConcept" : {
"coding" : [
{
"system" : "urn:oid:2.16.840.1.113883.15.16",
"code" : "T3",
"display" : "T3"
}
]
}
},
{
"code" : {
"coding" : [
{
"system" : "http://snomed.info/sct",
"code" : "277650004",
"display" : "m - Multiple tumors (tumor staging)"
}
]
},
"valueCodeableConcept" : {
"coding" : [
{
"system" : "urn:oid:2.16.840.1.113883.15.16",
"code" : "m",
"display" : "(m)"
}
]
}
},
{
"extension" : [
{
"url" : "https://www.vision-zero-oncology.de/fhir/StructureDefinition/uicc-tnm-prefix-cpu",
"valueCodeableConcept" : {
"coding" : [
{
"system" : "urn:oid:2.16.840.1.113883.15.16",
"code" : "p",
"display" : "p"
}
]
}
},
{
"url" : "https://www.vision-zero-oncology.de/fhir/StructureDefinition/uicc-tnm-suffix-itc",
"valueCodeableConcept" : {
"coding" : [
{
"system" : "urn:oid:2.16.840.1.113883.15.16",
"code" : "i+",
"display" : "(i+)"
}
]
}
}
],
"code" : {
"coding" : [
{
"system" : "http://loinc.org",
"code" : "21900-6",
"display" : "Regional lymph nodes.pathology [Class] Cancer"
}
]
},
"valueCodeableConcept" : {
"coding" : [
{
"system" : "urn:oid:2.16.840.1.113883.15.16",
"code" : "N0",
"display" : "N0"
}
]
}
},
{
"extension" : [
{
"url" : "https://www.vision-zero-oncology.de/fhir/StructureDefinition/uicc-tnm-prefix-cpu",
"valueCodeableConcept" : {
"coding" : [
{
"system" : "urn:oid:2.16.840.1.113883.15.16",
"code" : "c",
"display" : "c"
}
]
}
}
],
"code" : {
"coding" : [
{
"system" : "http://loinc.org",
"code" : "21907-1",
"display" : "Distant metastases.clinical [Class] Cancer"
}
]
},
"valueCodeableConcept" : {
"coding" : [
{
"system" : "urn:oid:2.16.840.1.113883.15.16",
"code" : "M0",
"display" : "M0"
}
]
}
}
]
}
IG © 2021+ Berlin Institute of Health at Charité (BIH). Package gold#0.1.0 based on FHIR 4.0.1. Generated 2023-12-13
Links: Table of Contents |
QA Report